Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Champlin

Showing results (221-230 of 279) with videos related to

Pageof 28
Sort By:
Cytotherapy|June 4, 2002
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancerI Braunschweig, N Q Mirza, G Rondon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Bone Marrow Transplantation|September 18, 2002
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaS Giralt, A Aleman, A Anagnostopoulos, et al.
Bone Marrow Transplantation|January 20, 2009
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndromeL De Padua Silva, M de Lima, H Kantarjian, et al.
Bone Marrow Transplantation|December 1, 1996
GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantationP Greenberg, R Advani, A Keating, et al.
Bone Marrow Transplantation|December 1, 1996
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantationM Körbling, P Anderlini, A Durett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1996
Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemiaD Seong, J M Bruner, K H Lee, et al.
Leukemia|October 3, 2003
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplantO Khorshid, E de Meis, T Martin, et al.
Cytotherapy|August 6, 2005
Ex vivo expansion of umbilical cord bloodS Robinson, T Niu, M de Lima, et al.
Bone Marrow Transplantation|March 3, 2015
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosisP Kongtim, M H Qazilbash, J J Shah, et al.
Pageof 28

Showing results (221-230 of 279) with videos related to

Sort By:
Pageof 28
Cytotherapy|June 4, 2002
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancerI Braunschweig, N Q Mirza, G Rondon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumorsY Nieto, S-M Tu, R Bassett, et al.
Bone Marrow Transplantation|September 18, 2002
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaS Giralt, A Aleman, A Anagnostopoulos, et al.
Bone Marrow Transplantation|January 20, 2009
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndromeL De Padua Silva, M de Lima, H Kantarjian, et al.
Bone Marrow Transplantation|December 1, 1996
GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantationP Greenberg, R Advani, A Keating, et al.
Bone Marrow Transplantation|December 1, 1996
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantationM Körbling, P Anderlini, A Durett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1996
Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemiaD Seong, J M Bruner, K H Lee, et al.
Leukemia|October 3, 2003
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplantO Khorshid, E de Meis, T Martin, et al.
Cytotherapy|August 6, 2005
Ex vivo expansion of umbilical cord bloodS Robinson, T Niu, M de Lima, et al.
Bone Marrow Transplantation|March 3, 2015
High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosisP Kongtim, M H Qazilbash, J J Shah, et al.
Pageof 28